RxDoctor Payments Data

Heidi Gibbons

Adult Health · Meadowbrook, PANPI 1477615946

Payments from drug & device makers

$1,747in general payments, 2019–2025

Across 99 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$443
  • Pfizer$341
  • Astellas Pharma US Inc$336
  • GSK$141
  • Novo Nordisk$136
  • Abbott$55
  • plus $295 from 11 others

What the payments were for

  • Food & beverage$1,56790%
  • Education$18010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,747 in reported general payments places this provider in the 75th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$5,941
Medicare patients
39
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin43$55,353
OzempicSemaglutide37$51,976
EliquisApixaban29$32,278
JanuviaSitagliptin Phosphate12$12,787
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$10,053
EntrestoSacubitril/Valsartan40$9,250
Breo ElliptaFluticasone/Vilanterol17$7,137
Atorvastatin Calcium273$4,148
Levothyroxine Sodium187$4,139
SymbicortBudesonide/Formoterol Fumarate14$3,730
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$2,666
Ezetimibe73$2,430
Rosuvastatin Calcium155$2,317
Metoprolol Succinate124$2,223
Valsartan22$1,998

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$16$55,35343 claims
Novo NordiskOzempic$136$51,97637 claims
PfizerEliquis$341$32,27829 claims
GSKAnoro Ellipta, Breo Ellipta$141$17,19039 claims
MerckJanuvia$14$12,78712 claims
AbbVieSynthroid$443$1,66631 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Meadowbrook

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →